Oncare, a cancer-care startup building a distributed oncology network, has raised Rs 27 crore (around $4 million) in a Series A funding round with participation from Huddle Ventures, Lotus Herbal Group, SteerX, and Caret Capital .

Where the money will go?

The company said it will use the fresh capital to expand into new metro markets as well as tier-II and tier-III cities, while also investing in technology infrastructure to streamline clinical operations, strengthen care delivery, and improve the patient experience.

What Oncare does?

Founded in 2023 by Amar Sneh and Deepak Kumar, Oncare operates a distributed oncology care model focused on making cancer treatment more affordable and standardised . The company’s approach integrates medical, surgical, and radiation oncology services within accredited hospitals, using what it describes as a capital-efficient model.

At present, Oncare operates four centres across Delhi NCR . It says it has built a multi-centre oncology platform within two years of launch and is targeting nationwide expansion.

Oncare had earlier raised $1 million in a seed round led by Huddle Ventures and others.

Why this matters?

In recent years, investor interest in oncology-focused startups has been picking up, with multiple companies in the segment raising capital . Oncare’s Series A adds to that momentum, especially as it positions itself around a “distributed” care model tied to accredited hospitals, rather than a standalone, asset-heavy expansion play.

The near-term story will be in execution: how quickly Oncare can replicate its Delhi NCR playbook in other metros and in tier-II and tier-III markets, while building the tech and clinical operating muscle it says it’s funding this round to strengthen.

Also Read: Adani Initiative Rekindles Hopes for Formula 1 Return to India